Ruri Kikura‐Hanajiri

Chemical analysis of synthetic cannabinoids as designer drugs in herbal products

Nahoko Uchiyama, Ruri Kikura‐Hanajiri, Jun Ogata et al. · Forensic Science International · 2010 · 246 citations

Cannabis Use, Medicinal Chemistry, Drug Analysis +12

Pharmacokinetics of Gemcitabine in Japanese Cancer Patients: The Impact of a Cytidine Deaminase Polymorphism

Emiko Sugiyama, Nahoko Kaniwa, Su-Ryang Kim et al. · Journal of Clinical Oncology · 2006 · 187 citations

Identification of a Cannabinoid Analog as a New Type of Designer Drug in a Herbal Product

Nahoko Uchiyama, Ruri Kikura‐Hanajiri, Nobuo Kawahara et al. · Chemical and Pharmaceutical Bulletin · 2009 · 172 citations · Full text

Two new-type cannabimimetic quinolinyl carboxylates, QUPIC and QUCHIC, two new cannabimimetic carboxamide derivatives, ADB-FUBINACA and ADBICA, and five synthetic cannabinoids detected with a thiophene derivative α-PVT and an opioid receptor agonist AH-7921 identified in illegal products

Nahoko Uchiyama, Satoru Matsuda, Maiko Kawamura et al. · Forensic Toxicology · 2013 · 162 citations

Cannabis Use, Molecular Pharmacology, Medicinal Chemistry +14

URB-754: A new class of designer drug and 12 synthetic cannabinoids detected in illegal products

Nahoko Uchiyama, Maiko Kawamura, Ruri Kikura‐Hanajiri et al. · Forensic Science International · 2012 · 153 citations

Cannabis Use, Substance Abuse, Medicinal Chemistry +15